# Black Rock Coffee Bar, Inc.: financial statements, quarterly BRCB · Nasdaq · CIK 2068577 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/brcb.md) · [Financials](/companies/brcb/financials.md) · [Filings](/companies/brcb/filings.md) · [Insiders](/companies/brcb/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/brcb/financials.md?period=annual). ## Income statement | Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [41.5](/filings/0001628280-25-051288.md) | [42.8 d](/filings/0001628280-26-014380.md) | [44.8](/filings/0001628280-26-034266.md) | [50.4](/filings/0001628280-26-055868.md) | [51.5](/filings/0001628280-25-051288.md) | [53.6 d](/filings/0001628280-26-014380.md) | [55.5](/filings/0001628280-26-034266.md) | [63.0](/filings/0001628280-26-055868.md) | | Selling, general and administrative | $m | [4.9](/filings/0001628280-25-051288.md) | [7.8 d](/filings/0001628280-26-014380.md) | [6.9](/filings/0001628280-26-034266.md) | [7.9](/filings/0001628280-26-055868.md) | [17.2](/filings/0001628280-25-051288.md) | [9.4 d](/filings/0001628280-26-014380.md) | [9.2](/filings/0001628280-26-034266.md) | [9.8](/filings/0001628280-26-055868.md) | | Operating income | $m | [3.1](/filings/0001628280-25-051288.md) | [(0.1) d](/filings/0001628280-26-014380.md) | [2.3](/filings/0001628280-26-034266.md) | [3.3](/filings/0001628280-26-055868.md) | [(6.4)](/filings/0001628280-25-051288.md) | [1.8 d](/filings/0001628280-26-014380.md) | [2.7](/filings/0001628280-26-034266.md) | [4.1](/filings/0001628280-26-055868.md) | | Income tax | $m | [0.1](/filings/0001628280-25-051288.md) | [0.1 d](/filings/0001628280-26-014380.md) | [0.1](/filings/0001628280-26-034266.md) | [0.1](/filings/0001628280-26-055868.md) | [0.0](/filings/0001628280-25-051288.md) | [0.2 d](/filings/0001628280-26-014380.md) | [0.1](/filings/0001628280-26-034266.md) | [0.1](/filings/0001628280-26-055868.md) | | Net income | $m | [(0.7)](/filings/0001628280-25-051288.md) | [(4.2) d](/filings/0001628280-26-014380.md) | [0.0](/filings/0001628280-26-034266.md) | [0.0](/filings/0001628280-26-055868.md) | [(0.7)](/filings/0001628280-25-051288.md) | [0.7 d](/filings/0001628280-26-014380.md) | [0.4](/filings/0001628280-26-034266.md) | [1.2](/filings/0001628280-26-055868.md) | | Diluted EPS | $ per share | not reported | not reported | not reported | not reported | [(0.05)](/filings/0001628280-25-051288.md) | not reported | [0.02](/filings/0001628280-26-034266.md) | [0.06](/filings/0001628280-26-055868.md) | | Basic EPS | $ per share | not reported | not reported | not reported | not reported | [(0.05)](/filings/0001628280-25-051288.md) | not reported | [0.02](/filings/0001628280-26-034266.md) | [0.06](/filings/0001628280-26-055868.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | period not labelled (2024-12-31) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [10.2](/filings/0001628280-26-014380.md) | [32.6](/filings/0001628280-25-051288.md) | [28.4](/filings/0001628280-26-055868.md) | [20.0](/filings/0001628280-26-034266.md) | [16.0](/filings/0001628280-26-055868.md) | | Current assets | $m | [19.4](/filings/0001628280-26-014380.md) | [44.1](/filings/0001628280-25-051288.md) | [40.1](/filings/0001628280-26-055868.md) | [30.5](/filings/0001628280-26-034266.md) | [28.8](/filings/0001628280-26-055868.md) | | Total assets | $m | [213](/filings/0001628280-26-014380.md) | [323](/filings/0001628280-25-051288.md) | [336](/filings/0001628280-26-055868.md) | [347](/filings/0001628280-26-034266.md) | [392](/filings/0001628280-26-055868.md) | | Current liabilities | $m | [33.3](/filings/0001628280-26-014380.md) | [32.1](/filings/0001628280-25-051288.md) | [38.6](/filings/0001628280-26-055868.md) | [35.1](/filings/0001628280-26-034266.md) | [40.7](/filings/0001628280-26-055868.md) | | Total liabilities | $m | [230](/filings/0001628280-26-014380.md) | [223](/filings/0001628280-25-051288.md) | [232](/filings/0001628280-26-055868.md) | [240](/filings/0001628280-26-034266.md) | [283](/filings/0001628280-26-055868.md) | | Long-term debt | $m | [89.3](/filings/0001628280-26-014380.md) | [17.6](/filings/0001628280-25-051288.md) | [25.9](/filings/0001628280-26-055868.md) | [26.4](/filings/0001628280-26-034266.md) | [29.4](/filings/0001628280-26-055868.md) | | Current portion of debt | $m | [0.9](/filings/0001628280-26-014380.md) | [1.3](/filings/0001628280-25-051288.md) | [0.8](/filings/0001628280-26-055868.md) | [1.0](/filings/0001628280-26-034266.md) | [1.2](/filings/0001628280-26-055868.md) | | Shareholders' equity | $m | [(258)](/filings/0001628280-26-014380.md) | [43.0](/filings/0001628280-25-051288.md) | [45.7](/filings/0001628280-26-055868.md) | [47.3](/filings/0001628280-26-034266.md) | [54.6](/filings/0001628280-26-055868.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [4.2 d](/filings/0001628280-26-014380.md) | [3.4](/filings/0001628280-26-034266.md) | [5.0 d](/filings/0001628280-26-055868.md) | [(11.3) d](/filings/0001628280-25-051288.md) | [5.1 d](/filings/0001628280-26-014380.md) | [6.8](/filings/0001628280-26-034266.md) | [12.4 d](/filings/0001628280-26-055868.md) | | Capital expenditure | $m | [3.9 d](/filings/0001628280-26-014380.md) | [6.5](/filings/0001628280-26-034266.md) | [8.5 d](/filings/0001628280-26-055868.md) | [7.9 d](/filings/0001628280-25-051288.md) | [12.0 d](/filings/0001628280-26-014380.md) | [16.2](/filings/0001628280-26-034266.md) | [16.9 d](/filings/0001628280-26-055868.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment ## Shares | Line item | Unit | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [14.8](/filings/0001628280-25-051288.md) | [17.6](/filings/0001628280-26-034266.md) | [21.2](/filings/0001628280-26-055868.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.